Velarion Records
Free. Unsubscribe any time.

Krystal Biotech, Inc. (KRYS)

Krystal Biotech, Inc. filed 21 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 183 transactions and 537,606 shares. None carries the SEC's AFF10B5ONE flag; all 21 name a plan in a footnote. 6 results prints are on file in the same window.

What stands out

Trades in Krystal Biotech, Inc. 183

Adoption dates in Krystal Biotech, Inc. 6

Results prints in Krystal Biotech, Inc. 6

Trades before a print in Krystal Biotech, Inc. 0

Interval to Krystal Biotech, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Krystal Biotech, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on June 13, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.